A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma

Abstract: Phase 3 studies combining histone deacetylase inhibitors with bortezomib were hampered by gastrointestinal (GI) intolerance, which was not observed when combined with immunomodulatory drugs. This study is a single-center phase 2 study of panobinostat with lenalidomide and dexamethasone (FR...

Full description

Bibliographic Details

Published in:	Blood Advances
Main Authors:	Ajai Chari, Hearn J. Cho, Amishi Dhadwal, Gillian Morgan, Lisa La, Katarzyna Zarychta, Donna Catamero, Erika Florendo, Nadege Stevens, Daniel Verina, Elaine Chan, Violetta Leshchenko, Alessandro Laganà, Deepak Perumal, Anna Huo-Chang Mei, Kaity Tung, Jami Fukui, Sundar Jagannath, Samir Parekh
Format:	Article
Language:	English
Published:	Elsevier 2017-08-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S2473952920302962